Afuco™ Anti-Human CD2 ADCC Therapeutic Antibody (BTI-322), ADCC Enhanced
Anti-CD2 ADCC Enhanced Antibody (BTI-322) is an ADCC enhanced antibody produced by our Afuco™ platform. BTI-322 is a monoclonal anti-CD2 antibody, for treatment of steroid-resistant acute graft-versus-host disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-106CL |
| Pricing | Inquiry |
| Host | Mouse |
| Target | CD2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | 4°C or -20°C, avoid repeated freezing and thawing. |